These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 15654550)
21. Use of medications for secondary prevention in stroke patients at hospital discharge in Australia. Eissa A; Krass I; Bajorek BV Int J Clin Pharm; 2014 Apr; 36(2):384-93. PubMed ID: 24519632 [TBL] [Abstract][Full Text] [Related]
22. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. Davis SM; Donnan GA N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297 [No Abstract] [Full Text] [Related]
24. Statins in hypertension: are they a new class of antihypertensive agents? Feldstein CA Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164 [TBL] [Abstract][Full Text] [Related]
25. Survey of blood pressure control status in patients with ischemic stroke or transient ischemic attack in China. Wang Y; Wu D; Zhou Y; Zhao X; Wang C; Liu L; Liao X; Wang Y Neurol Res; 2008 May; 30(4):348-55. PubMed ID: 18544250 [TBL] [Abstract][Full Text] [Related]
26. Optimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk level. Park JH; Ovbiagele B J Neurol Sci; 2015 Aug; 355(1-2):90-3. PubMed ID: 26044963 [TBL] [Abstract][Full Text] [Related]
27. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals? Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ; Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947 [TBL] [Abstract][Full Text] [Related]
29. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM; Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807 [TBL] [Abstract][Full Text] [Related]
30. Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry. Hwong WY; Abdul Aziz Z; Sidek NN; Bots ML; Selvarajah S; Kappelle LJ; Sivasampu S; Vaartjes I BMC Neurol; 2017 Nov; 17(1):203. PubMed ID: 29169331 [TBL] [Abstract][Full Text] [Related]
31. Secondary prevention after ischemic stroke or transient ischemic attack. Bangalore S; Schwamm L; Smith EE; Singh IM; Liang L; Fonarow GC; Bhatt DL; Am J Med; 2014 Aug; 127(8):728-38. PubMed ID: 24681258 [TBL] [Abstract][Full Text] [Related]
32. Interactions between hypercholesterolemia and hypertension: implications for therapy. Borghi C Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):489-96. PubMed ID: 12187312 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial. Uchiyama S; Nakaya N; Mizuno K; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Nakamura H; J Neurol Sci; 2009 Sep; 284(1-2):72-6. PubMed ID: 19423132 [TBL] [Abstract][Full Text] [Related]
34. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke. Po HL; Lin YJ; Hseuh IH Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361 [TBL] [Abstract][Full Text] [Related]
35. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Messé SR; Pervez MA; Smith EE; Siddique KA; Hellkamp AS; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Schwamm LH Stroke; 2013 May; 44(5):1354-9. PubMed ID: 23493734 [TBL] [Abstract][Full Text] [Related]
36. Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of Prevention After a Cerebrovascular evenT (IMPACT) Study. Touzé E; Coste J; Voicu M; Kansao J; Masmoudi R; Doumenc B; Durieux P; Mas JL Stroke; 2008 Jun; 39(6):1834-43. PubMed ID: 18388344 [TBL] [Abstract][Full Text] [Related]